Natera Inc
NTRA
Market Cap$11.68B
Close$
$97.68
11.9% upside
Current Fair Value
11.9% upsideUndervalued by 11.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.68 Billion |
|---|---|
| Enterprise Value | $11.16 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.78 |
| Beta | 1.14 |
| Outstanding Shares | 120,757,877 |
| Avg 30 Day Volume | 1,506,528 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -26.86 |
|---|---|
| PEG | 59.33 |
| Price to Sales | 10.91 |
| Price to Book Ratio | 14.55 |
| Enterprise Value to Revenue | 10.31 |
| Enterprise Value to EBIT | -25.02 |
| Enterprise Value to Net Income | -26 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.47 |
Revenue Sources
No data
ESG Score
No data
About Natera Inc
Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operat...